64 related articles for article (PubMed ID: 12353861)
21. Effect of leptin on intestinal re-growth following massive small bowel resection in rat.
Sukhotnik I; Vadasz Z; Coran AG; Lurie M; Shiloni E; Hatoum OA; Mogilner JG
Pediatr Surg Int; 2006 Jan; 22(1):9-15. PubMed ID: 16328335
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide endotoxemia reduces cell proliferation and decreases enterocyte apopotosis during intestinal adaptation in a rat model of short-bowel syndrome.
Sukhotnik I; Yakirevich E; Coran AG; Siplovich L; Krausz M; Sabo E; Kramer A; Shiloni E
Pediatr Surg Int; 2002 Oct; 18(7):615-9. PubMed ID: 12471477
[TBL] [Abstract][Full Text] [Related]
23. Low-fat diet impairs postresection intestinal adaptation in a rat model of short bowel syndrome.
Sukhotnik I; Shiloni E; Krausz MM; Yakirevich E; Sabo E; Mogilner J; Coran AG; Harmon CM
J Pediatr Surg; 2003 Aug; 38(8):1182-7. PubMed ID: 12891489
[TBL] [Abstract][Full Text] [Related]
24. Effect of subcutaneous insulin on intestinal adaptation in a rat model of short bowel syndrome.
Sukhotnik I; Mogilner J; Shamir R; Shehadeh N; Bejar J; Hirsh M; Coran AG
Pediatr Surg Int; 2005 Mar; 21(3):132-7. PubMed ID: 15756562
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy and growth factors in the treatment of short bowel syndrome.
Schwartz MZ; Kuenzler KA
Semin Pediatr Surg; 2001 May; 10(2):81-90. PubMed ID: 11329609
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials.
Li-Ling J; Irving M
Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865
[TBL] [Abstract][Full Text] [Related]
27. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.
Arnold R; Simon B; Wied M
Digestion; 2000; 62 Suppl 1():84-91. PubMed ID: 10940693
[TBL] [Abstract][Full Text] [Related]
28. Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR.
Tomassetti P; Migliori M; Corinaldesi R; Gullo L
Aliment Pharmacol Ther; 2000 May; 14(5):557-60. PubMed ID: 10792118
[TBL] [Abstract][Full Text] [Related]
29. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial.
Moloney M; Wilkinson M
Gastrointest Endosc; 2000 Mar; 51(3):372-4. PubMed ID: 10787299
[No Abstract] [Full Text] [Related]
30. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
Greenberg R; Haddad R; Kashtan H; Kaplan O
J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
[TBL] [Abstract][Full Text] [Related]
31. An analysis of the morbidity and mortality of short-bowel syndrome in the pediatric age group.
Coran AG; Spivak D; Teitelbaum DH
Eur J Pediatr Surg; 1999 Aug; 9(4):228-30. PubMed ID: 10532263
[TBL] [Abstract][Full Text] [Related]
32. Overview of intestinal adaptation and its stimulation.
Robinson MK; Ziegler TR; Wilmore DW
Eur J Pediatr Surg; 1999 Aug; 9(4):200-6. PubMed ID: 10532257
[TBL] [Abstract][Full Text] [Related]
33. Role of octreotide and somatostatin in the treatment of intestinal fistulae.
Dorta G
Digestion; 1999; 60 Suppl 2():53-6. PubMed ID: 10207232
[TBL] [Abstract][Full Text] [Related]
34. Short bowel syndrome.
Booth IW; Lander AD
Baillieres Clin Gastroenterol; 1998 Dec; 12(4):739-73. PubMed ID: 10079905
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor inhibits somatostatin-induced apoptosis.
Thompson JS
J Surg Res; 1999 Jan; 81(1):95-100. PubMed ID: 9889066
[TBL] [Abstract][Full Text] [Related]
36. Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat.
Vanderhoof JA; Kollman KA
J Pediatr Gastroenterol Nutr; 1998 Mar; 26(3):241-4. PubMed ID: 9523855
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal endocrine tumours: medical management.
Arnold R; Frank M
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):737-59. PubMed ID: 9113320
[TBL] [Abstract][Full Text] [Related]
38. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.
Beaugerie L; Baumer P; Chaussade S; Berard H; Rozenbaum W; Pialoux G; Le Quintrec Y; Schwartz JC; Lecomte JM
Eur J Gastroenterol Hepatol; 1996 May; 8(5):485-9. PubMed ID: 8804878
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin analogue inhibits intestinal regeneration.
Thompson JS; Nguyen BL; Harty RF
Arch Surg; 1993 Apr; 128(4):385-9. PubMed ID: 8457151
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Harris AG
Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
